Litcius/Paper detail

Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies

Helena Domin

2021Progress in Neuro-Psychopharmacology and Biological Psychiatry28 citationsDOI

Topics & Concepts

NeuroprotectionAntidepressantMedicineNeuroscienceDiseaseExcitotoxicityNeuropeptide Y receptorDepression (economics)BioinformaticsPharmacologyPsychiatryReceptorPsychologyBiologyInternal medicineNeuropeptideAnxietyGlutamate receptorMacroeconomicsEconomicsNeuropeptides and Animal PhysiologyReceptor Mechanisms and SignalingPharmacological Receptor Mechanisms and Effects
Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies | Litcius